These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1262 related items for PubMed ID: 8923869

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 23. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
    Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4374-80. PubMed ID: 16940442
    [Abstract] [Full Text] [Related]

  • 24. Oestradiol enhances testosterone-induced suppression of human spermatogenesis.
    Handelsman DJ, Wishart S, Conway AJ.
    Hum Reprod; 2000 Mar; 15(3):672-9. PubMed ID: 10686218
    [Abstract] [Full Text] [Related]

  • 25. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception.
    Brady BM, Walton M, Hollow N, Kicman AT, Baird DT, Anderson RA.
    Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J, Bartsch G, Jakse G.
    Urol Res; 1977 Nov; 5(2):55-9. PubMed ID: 69351
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels.
    Frick J, Bartsch G, Weiske WH.
    Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192
    [Abstract] [Full Text] [Related]

  • 30. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception.
    Anderson RA, Kinniburgh D, Baird DT.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488
    [Abstract] [Full Text] [Related]

  • 31. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.
    Barfield A, Melo J, Coutinho E, Alvarez-Sanchez F, Faundes A, Brache V, Leon P, Frick J, Bartsch G, Weiske WH, Brenner P, Mishell D, Bernstein G, Ortiz A.
    Contraception; 1979 Aug; 20(2):121-7. PubMed ID: 487815
    [Abstract] [Full Text] [Related]

  • 32. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata).
    Shetty G, Krishnamurthy H, Krishnamurthy HN, Ramachandra SG, Moudgal NR.
    Contraception; 1997 Oct; 56(4):257-65. PubMed ID: 9408708
    [Abstract] [Full Text] [Related]

  • 33. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive.
    Brenner PF, Mishell DR, Bernstein GS, Ortiz A.
    Contraception; 1977 Jun; 15(6):679-91. PubMed ID: 891194
    [Abstract] [Full Text] [Related]

  • 37. Influence of testosterone substitution on sperm suppression by LHRH agonists.
    Bouchard P, Garcia E.
    Horm Res; 1987 Jun; 28(2-4):175-80. PubMed ID: 2969861
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens.
    Ly LP, Liu PY, Handelsman DJ.
    Hum Reprod; 2005 Jun; 20(6):1733-40. PubMed ID: 15860500
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 64.